TrialJournal of clinical laboratory analysis2019

Increased serum adiponectin predicts improved coronary flow and clinical outcomes in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention.

Siwen Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.